Hepatorenal glycogenosis (type I glycogenosis) and carcinoma of the liver.
D000293:Adolescent; D006528:Carcinoma, Hepatocellular / Q000150:complications* / Q000201:enzymology / Q000473:pathology; D003348:Cortisone / Q000627:therapeutic use; D006003:Glycogen / Q000032:analysis / Q000378:metabolism; D006008:Glycogen Storage Disease / Q000150:complications* / Q000188:drug therapy; D005953:Glycogen Storage Disease Type I / Q000150:complications* / Q000188:drug therapy; D006505:Hepatitis / Q000150:complications; D006801:Humans; D008099:Liver / Q000201:enzymology; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000150:complications* / Q000201:enzymology / Q000473:pathology; D008297:Male; D008854:Microscopy, Electron; D009639:Norethandrolone / Q000627:therapeutic use
D006003:Glycogen; D009639:Norethandrolone; D003348:Cortisone